Paracetamol: New vistas of an old drug

CNS Drug Reviews

Volumn 12, Issue 3-4, 2006, Pages 250-275

  Bertolini, Alfío ^a,c   Ferrari, Anna ^a   Ottani, Alessandra ^a   Guerzoni, Simona ^a   Tacchi, Raffaella ^a   Leone, Sheila ^b  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

^c UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Acetaminophen; Cannabinoids; CB1 receptors; Centrally acting analgesics; Paracetamol

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N MORPHOLINO 1H PYRAZOLE 3 CARBOXAMIDE; ACENOCOUMAROL; ACETYLSALICYLIC ACID; ANTICONVULSIVE AGENT; ARACHIDONIC ACID; CANNABINOID; CANNABINOID 1 RECEPTOR; CANNABINOID RECEPTOR AGONIST; CANNABINOID RECEPTOR ANTAGONIST; CARBAMAZEPINE; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2 INHIBITOR; CYTOCHROME P450; DEXANABINOL; FOSPHENYTOIN SODIUM; ISONIAZID; LAMOTRIGINE; N (4 HYDROXYPHENYL)ARACHIDONAMIDE; N ACETYL 1,4 BENZOQUINONE IMINE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PARACETAMOL; PHENACETIN; PHENYTOIN; PLACEBO; PROSTAGLANDIN SYNTHASE; RIMONABANT; SULFINPYRAZONE; WARFARIN;

ALCOHOLISM; ANALGESIA; ANTIINFLAMMATORY ACTIVITY; BLEEDING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEACETYLATION; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG ELIMINATION; DRUG INDICATION; DRUG METABOLISM; DRUG STRUCTURE; DRUG USE; ENZYME INHIBITION; FEVER; GLOMERULUS FILTRATION RATE; HEMODIALYSIS; HUMAN; LIVER TOXICITY; NONHUMAN; PAIN; POSTOPERATIVE PAIN; REVIEW; URINARY EXCRETION;

ACETAMINOPHEN; ANALGESICS, NON-NARCOTIC; ANIMALS; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; PAIN;

EID: 33846008062     PISSN: 1080563X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1527-3458.2006.00250.x     Document Type: Review

References (235)

1. Abbadie C, Besson JM. C-fos expression in rat lumbar spinal cord during the development of adjuvant-induced arthritis. Neuroscience 1992;48:985-993.
2. Abbadie C, Besson JM. Chronic treatments with aspirin or acetaminophen reduce both the development of polyarthritis and Fos-like immunoreactivity in rat lumbar spinal cord. Pain 1994;57:45-54.
3. Abbott FV, Hellemans KG. Phenacetin, acetaminophen and dipyrone: Analgesic and rewarding effects. Behav Brain Res 2000;112:177-186.
4. Airaksinen O, Brox JI, Cedraschi C. European guidelines for the management of chronic non-specific low back pain. Eur Spine J 2006;15(Suppl 2):S192-S300.
5. Albert KS, Sedman AJ, Wagner JG. Pharmacokinetics of orally administered acetaminophen in man. J Pharmacokinet Biopharm 1974;2:381-393.
6. Anderson BJ, Holford NHG, Woollard GA, Chan PLS. Paracetamol plasma and cerebrospinal fluid pharmacokinetics in children. Br J Clin Pharmacol 1998;46:237-243.
7. Anderson BJ, Holford NHG, Woollard GA, et al. Perioperative pharmacodynamics of acetaminophen analgesia in children. Anesthesiology 1999;90:411-421.
8. Anderson BJ, Monteleone J, Holford NH. Variability of concentrations after rectal paracetamol [Letter]. Paediatr Anaesth 1998;8:324.
9. Anderson BJ, Woollard GA, Holford NHG. Pharmacokinetics of rectal paracetamol after major surgery in children. Paediatr Anaesth 1995;5:237-242.
10. Anderson RJ, Gambertoglio JG, Schrier RW. Clinical Use of Drugs in Renal Failure. Springfield: Charles C Thomas, 1976;213.
11. Arena JM, Rourk MHJ, Sibrack CD. Acetaminophen: Report of an unusual poisoning. Pediatrics 1978;61:68-72.
12. Bae YC, Oh JM, Hwang SJ, et al. Expression of vanilloid receptor TRPV1 in the rat trigeminal sensory nuclei. J Comp Neurol 2004;478:62-71.
13. Bannwarth B, Netter P, Lapicque F, et al. Plasma and cerebrospinal fluid concentrations of paracetamol after a single intravenous dose of paracetamol. Br J Clin Pharmacol 1992;34:79-81.
14. Bannwarth B, Pehourco F, Lagrange F, et al. Single and multiple dose pharmacokinetics of acetaminophen (Paracetamol) in polymedicated very old patients with rheumatic pain. J Rheumatol 2001;28:182-184.
15. Barden J, Edwards J, Moore A, et al. Single dose oral paracetamol (acetaminophen) for postoperative pain (Cochrane Review). Cochrane Lib 2004;1:1-54.
16. Barker JD Jr, de Carle DJ, Anuras S. Chronic excessive acetaminophen use and liver damage. Ann Intern Med 1977;87:299-301.
17. Barr R, Wentowski C, Curhan G, et al. Prospective study of acetaminophen use and newly diagnosed asthma among women. Am J Respir Crit Care Med 2004;169:836-841.
18. Beck DH, Schenk MR, Hagemann K, et al. The pharmacokinetics and analgesic efficacy of larger dose rectal acetaminophen (40 mg/kg) in adults: A double-blinded, randomized study. Anesth Analg 2000;90:431-436.
19. Beltramo M, Stella N, Calignano A, Lin SY, et al. Functional role of high-affinity anandamide transport, as revealed by selective inhibition. Science 1997;277:1094-1097.
20. rd Edition. Philadelphia: American College of Physicians, 1994.
21. Bentley E, Mackie IC. Trends in prescriptions of paracetamol for children. Br Med J 1995;311:362.
22. Bentley KC, Head TW. The additive analgesic efficacy of acetaminophen, 1000 mg, and codeine, 60 mg, in dental pain. Clin Pharmacol Ther 1987;42:634-640.
23. Bertolini A, Ottani A, Sandrini M. Selective COX-2 inhibitors and dual acting anti-inflammatory drugs: Critical remarks. Curr Med Chem 2002;9:1033-1043.
24. Birmingham P, Tobin M, Henhorn T, et al. Twenty-four-hour pharmacokinetics of rectal acetaminophen in children. Anestesiology 1997;87:244-252.
25. 1 cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivo. Biochem J 2002;315:817-824.
26. th Edition. New York: McGraw-Hill, 2002;480-501.
27. Bjorkman R, Hallman KM, Hedner T, Henning M. Acetaminophen blocks spinal hyperalgesia induced by NMDA and substance P. Pain 1994;57:259-264.
28. Blume H, Ali SL, Elze M, et al. Relative bioavailability of paracetamol in suppository preparation in comparison to tablets. Arzneimittelforschung 1994;44(12):1333-1338.
29. Boeijinga JJ, Boerstra EE, Ris P, et al. Interaction between paracetamol and coumarin anticoagulants. Lancet 1982;1:506.
30. Borin MT, Ayres JW. Single dose availability of acetaminophen following oral absorption. Int J Pharm 1989;54:199-209.
31. Botting R, Ayoub SS. COX-3 and the mechanism of action of paracetamol/acetaminophen. Prostaglandins Leukot Essent Fatty Acids 2005;72:85-87.
32. 2 synthases. Proc Natl Acad Sci USA 2002;99:7130-7135.
33. Bowman WC, Rand MJ. Textbook of Pharmacology. Oxford: Blackwell Scientific Publications, 1980.
34. Breen K, Wandscheer JC, Peignoux M, Pessayre D. In situ formation of the acetaminophen metabolite covalently bound in kidneys and lung. Supportive evidence provided by total hepatectomy. Biochem Pharmacol 1982;31:115-116.
35. Brent JA. New ways of looking at an old molecule. J Toxicol Clin Toxicol 1996;34:149-153.
36. Brodie BB, Axelrod J. The fate of acetanilide in man. J Pharmacol Exp Ther 1948;94:29-38.
37. Bromm B, Forth W, Richter E, Scharein E. Effects of acetaminophen and antipyrine on non-inflammatory pain and EEG activity. Pain 1992;50:213-221.
38. Brooks PM, Day RO. Nonsteroidal antiinflammatory drugs-differences and similarities. N Engl J Med 1991;324:1716-25.
39. th Edition. New York: McGraw-Hill, 2006.
40. Buckpitt AR, Rollins DE, Mitchell JR. Varying effects of sulfhydryl nucleophiles on acetaminophen oxidation and sulfhydryl adduct formation. Biochem Pharmacol 1979;28:2941-2946.
41. Bujalska M. Effect of nitric oxide synthase inhibition on antinociceptive action of different doses of acetaminophen. Pol J Pharmacol 2004;56:605-610.
42. Burger DM, Meenhorst PL, Koks CH, et al. Pharmacokinetics of zidovudine and acetaminophen in a patient on chronic acetaminophen therapy. Ann Pharmacother 1994;28:327-330.
43. Calvert LJ, Linder CW. Acetaminophen poisoning. J Fam Pract 1978;7:953-956.
44. Campbell NR, Baylis B. Renal impairment associated with an acute paracetamol overdose in the absence of hepatotoxicity. Postgrad Med J 1992;68:116-118.
45. Carlsson J. Central analgesic effect of paracetamol manifested by depression of nociceptive activity in thalamic neurones of the rat. Neurosci Lett 1987;77:339-343.
46. Catella-Lawson F, Reilly MP, Kapoor SC, et al. Cyclooxygenase inhibitors and the antiplatelet effects of aspirin. N Engl J Med 2001;345:1809-1817.
47. Chan A, Hepp P. Das Antifebrin, ein neues Fiebermittel. Centralbl Klein Med 1886;7:561-564.
48. Chandrasekharan NV, Dai H, Roos KL, et al. COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: Cloning, structure, and expression. Proc Natl Acad Sci USA 2002;99:13926-13931.
49. Chao TC. Adverse drug reactions: Tales of a forensic pathologist. Ann Acad Med Singapore 1993;22:86-89.
50. Chen W, Koenigs LL, Thompson SJ, et al. Oxidation of acetaminophen to its toxic quinone imine and non-toxic catechol metabolites by baculovirus-expressed and purified human cytochromes P450 2E1 and 2A6. Chem Res Toxicol 1998;11:295-301.
51. Cichewicz DL. Synergistic interactions between cannabinoid and opioid analgesics. Life Sci 2004;74:1317-1324.
52. Clark JH, Russell GJ, Fitzgerald JF. Fatal acetaminophen toxicity in a 2-year-old. J Indiana State Med Assoc 1983;76:832-835.
53. Clements JA, Heading RC, Nimmo WS, et al. Kinetics of acetaminophen absorption and gastric emptying in man. Clin Pharmacol Ther 1978;24:420-431.
54. Clissold SP. Paracetamol and phenacetin. Drugs 1986;32(Suppl 4):46-59.
55. Cobden I, Record CO, Ward MK, Kerr DNS. Paracetamol-induced acute renal failure in the absence of fulminant liver damage. Br Med J 1982;284:21-22.
56. Collins R, Peto R, MacMahon S, et al. Blood pressure, stroke, and coronary heart disease. Part 2. Short-term reductions in blood pressure: Overview of randomised drug trials in their epidemiological context. Lancet 1990;335:827-838.
57. Cooper SA, Precheur H, Rauch D, et al. Evaluation of oxycodone and acetaminophen in treatment of postoperative dental pain. Oral Surg Oral Med Oral Pathol 1980;50:496-501.
58. Corcoran GB, Mitchell JR, Vaishnav YN, et al. Evidence that acetaminophen and N-hydroxyacetaminophen form a common arylating intermediate, N-acetyl-p-benzoquinoneimine. Mol Pharmacol 1980;18:536-542.
59. Coulthard KP, Nielson HW, Schroder M, et al. Relative bioavailability and plasma paracetamol profiles of Panadol suppositories in children. J Paediatr Child Health 1998;34(5):425-431.
60. Cullen S, Kenny D, Ward OC, Sabra K. Paracetamol suppositories: A comparative study. Arch Dis Child 1989;64:1504-1505.
61. Curry RW, Robinson JD, Sughrue MJ. Acute renal failure after acetaminophen ingestion. JAMA 1982;247:1012-1014.
62. Dahlin DC, Miwa GT, Lu AY, Nelson SD. N-Acetyl-p-benzoquinone imine: A cytochrome P-450-mediated oxidation product of acetaminophen. Proc Natl Acad Sci USA 1984;81:1327-1331.
63. Davenport A, Finn R. Paracetamol (acetaminophen) poisoning resulting in acute renal failure without hepatic coma. Nephron 1988;50:55-56.
64. Davis M, Labadarios D, Williams RS. Metabolism of paracetamol after therapeutic and hepatotoxic doses in man. J Int Med Res 1976;4(Suppl 4):40-45.
65. Day A, Abbott GD. Chronic paracetamol poisoning in children: A warning to health professionals. N Zealand Med J 1994;107:201.
66. De Petrocellis, Bisogno T, Davis JB, et al. Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: Inhibitors of anandamide uptake with negligible capsaicin-like activity. FEBS Lett 2000;483:52-56.
67. Depot M, Powell JR, Messenheimer JA Jr, et al. Kinetic effects of multiple oral doses of acetaminophen on a single oral dose of lamotrigine. Clin Pharmacol Ther 1990;48:346-355.
68. Detry O, Arkavopoulos N, Ting P, et al. Clinical use of bioartificial liver in the treatment of acetaminophen-induced fulminant hepatic failure. Am Surg 1999;65:934-938.
69. Devane WA, Hanus L, Breuer A, et al. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 1992;258:1946-1949.
70. Devlin J, Ellis AE, McPeake J, et al. N-Acetylcysteine improves indocyanine green extraction and oxygen transport during hepatic dysfunction. Crit Care Med 1997;25:236-242.
71. Di Marzo V, Bifulco M, De Petrocellis L. The endocannabinoid system and its therapeutic exploitation. Nat Rev Drug Discov 2004;3:771-84.
72. Divoll M, Greenblatt DJ, Ameer B, et al. Effect of food on acetaminophen absorption in young and elderly subjects. J Clin Pharmacol 1982;22:571-576.
73. Douglas DR, Sholar JB, Smilkstein MJ. A pharmacokinetic comparison of acetaminophen products (Tylenol Extended relief vs. regular Tylenol). Acad Emerg Med 1996;3:740-744.
74. Douidar SM, Al-Khalil I, Habersang RW. Severe hepatotoxicity, acute renal failure, and pancytopenia in a young child after repeated acetaminophen overdosing. Clin Pediatr 1994;33:42-45.
75. Draganov P, Durrence H, Cox C, et al. Alcohol-acetaminophen syndrome. Postgrad Med 2000;107:189-195.
76. Eade NR, Lasagna LA. A comparison of acetophenetidin and acetaminophen. II. Subjective effects in healthy volunteers. J Pharmacol Exp Ther 1967;155:301-308.
77. 1 cannabinoid receptor expression in the mouse brain: Evidence of a widespread role for fatty acid amide hydrolase in regulation of endocannabinoid signalling. Neuroscience 2003;119:481-496.
78. Ellenhorn MJ, Barceloux DG, Eds. Medical Toxicology: Diagnosis and Treatment of Human Poisoning. New York: Elsevier Science Publishing Company, 1988.
79. nd Edition. Baltimore: Williams & Wilkins, 1997; 189.
80. Emeigh-Hart SG, Beierscmitt WP, Wyand DS, et al. Acetaminophen nephrotoxicity in CD-1 mice. I. Evidence of a role for in situ activation in selective covalent binding and toxicity. Toxicol Appl Pharmacol 1994;126:267-275.
81. Feenstra J, Grobbee De, Monsterd A, Stricker BHC. Adverse cardiovascular effects of NSAIDs in patients with congestive heart failure. Drugs Saf 1997;17:166-180.
82. Fegley D, Kathuria S, Mercier R, et al. Anandamide transport is independent of fatty-acid amide hydrolase activity and is blocked by the hydrolysis-resistant inhibitor AM1172. Proc Natl Acad Sci USA 2004;101:8756-8761.
83. th Edition. New York: Macmillan, 1980;706.
84. Flower RJ, Vane JR. Inhibition of prostaglandin synthetase in brain explains the anti-pyretic activity of paracetamol (4-acetamidophenol). Nature 1972;240:410-411.
85. Gaziano JM, Gibson CM. Potential for drug-drug interactions in patients taking analgesics for mild-to-moderate pain and low-dose aspirin for cardioprotection. Am J Cardiol 2006;97(Suppl 9A):23E-29E.
86. Gazzard BG, Ford-Hutchinson AW, Smith MJH, Williams R. The binding of paracetamol to plasma proteins of man and pig. J Pharm Pharmacol 1973;25:964-967.
87. th Edition. New York: Macmillan Publishing Co., 1990.
88. Gilmore IT, Tourvas E. Paracetamol induced acute pancreatitis. Br Med J 1977;1:753-754.
89. Graf WD, Riback PS. Pharmacologic treatment of recurrent pediatric headache. Pediatr Ann 1995;24:477-484.
90. Graham GG, Scott KF. Mechanism of action of paracetamol. Am J Ther 2005;12:46-55.
91. Greenberg LA. Antipyrine: A critical bibliographic review. New Haven, Connecticut: Hillhouse Press, 1950.
92. Guhring H, Hamza M, Sergejeva M, et al. A role for endocannabinoids in indomethacin-induced spinal antinociception. Eur J Pharmacol 2002;454:153-163.
93. Gurwitz JH, Avorn J, Bohn RL, et al. Initiation of antihypertensive treatment during nonsteroidal anti-inflammatory drug therapy. JAMA 1994;272:781-786.
94. Hanel AM, Lands WE. Modification of anti-inflammatory drug effectiveness by ambient lipid peroxides. Biochem Pharmacol 1982;31:3307-3311.
95. Hansen TG, O'Brien K, Morton NS, et al. Plasma paracetamol concentrations and pharmacokinetics following rectal administration in neonates and young infants. Acta Anaesthesiol Scand 1999;43(8):855-859.
96. Harrison PM, Wendon JA, Gimson AES, et al. Improvement by acetylcysteine of hemodynamics and oxygen transport in fulminant hepatic failure. N Engl J Med 1991;324:1852-1857.
97. Hart SG, Beierschmitt WP, Wyand DS, et al. Acetaminophen nephrotoxicity in CD-1 mice. Evidence of a role for in situ activation in selective covalent binding and toxicity. Toxicol Appl Pharmacol 1994;126:216-275.
98. Heerdink ER, Leufkens HG, Herings RMC, et al. NSAIDs associated with increased risk of congestive heart failure in elderly patients taking diuretics. Arch Intern Med 1998;158:1108-1112.
99. Henretig FM, Selbst SM, Forrect C, et al. Repeated acetaminophen overdosing. Causing hepatotoxicity in children. Clinical reports and literature review. Clin Pediatr 1989;28:525-8.
100. Herrero JF, Headly PM. Reversal by naloxone of the spinal antinociceptive actions of a systemically administered NSAIDs. Br J Pharmacol 1996;118:968-972.
101. Hoffmeister F, Dycka J, Ramsch K. Intragastric self-administration in the rhesus monkey: A comparison of the reinforcing effects of codeine, phenacetin and paracetamol. J Pharm Exp Ther 1980;214:213-218.
102. Hogestatt ED, Jonsson BAG, Ermund A. Conversion of acetaminophen to the bioactive N-acylphenolamine AM404 via fatty acid amide hydrolase-dependent arachidonic acid conjugation in the nervous system. J Biol Chem 2005;280(36):31405-31412.
103. Hoivik DJ, Manautou JE, Tviet A, et al. Gender-related differences in susceptibility to acetaminophen-induced protein arylation and nephrotoxicity on the CD-1 mouse. Toxicol Appl Pharmacol 1995;130:257-271.
104. Houston MC. Nonsteroidal anti-inflammatory drugs and antihypertensives. Am J Med 1991;90(Suppl 5A):42S-47S.
105. Huang SM, Bisogno T, Petros TJ, et al. Identification of a new class of molecules, the arachidonyl amino acids, and characterization of one member that inhibits pain. J Biol Chem 2001;276:42639-42644.
106. Huang SM, Bisogno T, Trevisani M, et al. An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors. Proc Natl Acad Sci USA 2002;99:8400-8405.
107. Hunskaar S, Fasmer OB, Hole K. Acetylsalicylic acid, paracetamol and morphine inhibit behavioural responses to intrathecally administered substance P or capsaicin. Life Sci 1985;37:1835-1841.
108. James LP, McCullough SS, Lamps LW, Hinson JA. Effect of N-acetylcysteine on acetaminophen toxicity in mice: Relationship to reactive nitrogen and cytokine formation. Toxicol Sci 2003;75:458-467.
109. Janusz JM, Buckwalter BL, Young PA, et al. Vanilloids. 1. Analogs of capsaicin with antinociceptive and antiinflammatory activity. J Med Chem 1993;36:2595-2604.
110. Johnson AG, Nguyen TV, Day RO. Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis. Ann Intern Med 1994;121:289-300.
111. Karai L, Brown DC, Mannes AJ, et al. Deletion of vanilloid receptor 1-expressing primary afferent neurons for pain control. J Clin Invest 2004;113:1344-1352.
112. Kis B, Snipes JA, Busija DW. Acetaminophen and the COX-3 puzzle: Sorting out facts, fictions and uncertainties. J Pharmacol Exp Ther 2005;315:1-7.
113. Kolloffel WJ, Driessen FG, Goldhoorn PB. Plasma concentration profiles after pre-operative rectal administration of a solution of paracetamol in children. Pharm World Sci 1996;18(3):105-108.
114. Korpela R, Korvenoja P, Meretoja OA. Morphine-sparing effect of acetaminophen in pediatric day-case surgery. Anesthesiology 1999;91(2):442-447.
115. Kwan D, Bartle WR, Walker SE. The effects of acetaminophen on pharmacokinetics and pharmacodynamics of warfarin. J Clin Pharmacol 1999;39:68-75.
116. Lauterburg BH, Corcoran GB, Mitchell JR. Mechanism of action of N-acetylcysteine in the protection against hepatotoxicity of acetaminophen in rats in vivo. J Clin Invest 1983;71:980-991.
117. Lauterburg BH, Vaishnav Y, Stillwell WG, et al. The effect of age and glutathione depletion on hepatic glutathione turnover in vivo determined by acetaminophen probe analysis. J Pharmacol Exp Ther 1980;213:54-58.
118. Lauterburg BH, Velez ME. Glutathione deficiency in alcoholics: Risk factor for paracetamol hepatotoxicity. Gut 1988;29:1153-1157.
119. Levy G, Garrettson LK, Soda DM. Evidence of placental transfer of acetaminophen [Letter]: Pediatrics 1975;55:895.
120. Licht H, Seeff LB, Zimmerman HJ. Apparent potentiation of acetaminophen hepatotoxicity by alcohol [Letter]. Ann Intern Med 1980;92:511.
121. Lieber CS, Lasker JM, Alderman J, et al. The microsomal ethanol oxidizing system and its interaction with other drugs, carcinogens, and vitamins. Ann NY Acad Sci 1987;492:11-24.
122. Lieh-Lai MW, Sarnaik AP, Newton JF, et al. Metabolism and pharmacokinetics of acetaminophen in a severely poisoned young child. J Pediatr 1984;105:125-128.
123. Lin YC, Sussman HH, Benitz WE. Plasma concentrations after rectal administration of acetaminophen in preterm neonates. Paediatr Anaest 1997;7:457-459.
124. Lip GYH, Vale JA. Does acetaminophen damage the heart? J Toxicol Clin Toxicol 1996;34:145-147.
125. Liu ZX, Han D, Gunawan B, Kaplowitz N. Neutrophil depletion protects against murine acetaminophen hepatotoxicity. Hepatology 2006;43:1220-1230.
126. Lokken P, Skoglund LA, Skjelbred P. Anti-inflammatory efficacy of treatments with aspirin and acetaminophen. Pain 1995;60:231-232.
127. Lucas R, Warner TD, Vojnovic I, et al. Cellular mechanism of acetaminophen: Role of cyclo-oxygenase. FASEB J 2005;19:635-637.
128. Makin AJ, Williams R. The current management of paracetamol overdosage. Br J Clin Prac 1994;48:144-148.
129. Mc Junkin B, Barwick KW, Little WC, et al. Fatal massive hepatic necrosis following acetaminophen overdose. JAMA 1976;236:1874-1875.
130. McCrae TA, Furuhama K, Roberts DW, et al. Evaluation of 3-(cys-tein-S-yl) acetaminophen in the nephrotoxicity of acetaminophen in rats. Toxicologist 1989;9:47.
131. McGrath PA, Hillier LM, Eds. The Child With Headache: Diagnosis and Treatment. Seattle: IASP Press, 2001;12.
132. McQuay HJ, Moore RA. Postoperative analgesia and vomiting, with special reference to day-case surgery: A systemic review. Health Technol Assess 1998;2(12):1-236.
133. McQueen DS, Iggo A, Barrel GI, Grubb BD. Effects of paracetamol and aspirin on neural activity of joint mechanonociceptors in adjuvant arthritis. Br J Pharmacol 1991;104:178-182.
134. Mehlisch DR, Frakes LA. A controlled comparative evaluation of acetaminophen and aspirin in the treatment of postoperative pain. Clin Ther 1984;7(1):89-97.
135. Mehlisch DR. The efficacy of combination analgesic therapy in relieving dental pain. Jada 2002;133:861-871.
136. 1 cannabinoid receptors. Biochem Biophys Res Commun 1999;262:275-284.
137. Meng ID, Manning BH, Martin WJ, et al. An analgesia circuit activated by cannabinoids. Nature 1998;395:381-383.
138. Meredith TJ, Goulding R. Paracetamol. Postgrad Med J 1980;56:459-73.
139. Merlo J, Broms K, Lindblad U, et al. Association of outpatient utilisation of non-steroidal anti-inflammatory drugs and hospitalised heart failure in the entire Swedish population. Eur J Clin Pharmacol 2001;57:71-75.
140. Mezey E, Toth ZE, Cortright DN, et al. Distribution of mRNA for vanilloid receptor subtype 1 (VR1), and VR1-like immunoreactivity, in the central nervous system of the rat and human. Proc Natl Acad Sci USA 2000;97:3655-3660.
141. Miller RP, Roberts RJ, Fischer LJ. Acetaminophen elimination kinetics in neonates, children and adults. Clin Pharmacol Ther 1976;19:284-294.
142. Miners JO, Attwood J, Birkett DJ. Determinants of acetaminophen metabolism: Effect of inducers and inhibitors of drug metabolism on acetaminophen's metabolic pathways. Clin Pharmacol Ther 1984;35:480-486.
143. Mitchell JR, Jollow DJ, Potter WZ, et al. Acetaminophen-induced hepatic necrosis. IV. Protective role of glutathione. J Pharmacol Exp Ther 1973;187:211-217.
144. Mitic-Zlatkovic M, Stefanovic V. Acute effects of acetaminophen on renal function and urinary excretion of some proteins and enzymes in patients with kidney disease. Ren Fail 1999;21:525-532.
145. Mofenson HC, Caraccio TR, Nawaz H, Steckler G. Acetaminophen-induced pancreatitis. Clin Toxicol 1991;29:223-230.
146. Montgomery CJ, McCormack JP, Reichert CC, Marsland CP. Plasma concentrations after high-dose (45 mg/kg) rectal acetaminophen in children. Can J Anaesth 1995;42(11):982-986.
147. Morris ME, Levy G. Renal clearance and serum protein binding of acetaminophen and its major conjugates in humans. J Pharm Sci 1984;73:1038-1041.
148. Morse HN. Ueber eine neue Darstellungsmethode der Acetylamidophenole. Ber Deutscher Chem Ges 1878;11:232-233.
149. Murray RM. Dependence on analgesics in analgesic nephropathy. Br J 1Addict 1973;68:265-272.
150. Narvanen T, Halsas M, Smal J, Marvola M. Is one paracetamol suppository of 1000 mg bioequivalent with two suppositories of 500 mg. Eur J Drug Metab Pharmacokinet 1998;23(2):203-206.
151. Nogen AG, Bremner JE. Fatal acetaminophen overdosage in a young child. J Pediatr 1978;92:832-833.
152. O'Grady JG, Wendon JA, Tan KC, et al. Liver transplantation after paracetamol overdose. Br Med J 1991;303:221-223.
153. Oie S, Lowenthal DT, Briggs WA, et al. Effect of hemodialysis on kinetics of acetaminophen elimination by anephric patients. Clin Pharmacol Ther 1975;18:680-686.
154. 1 receptors. Eur J Pharmacol 2006;531:280-281.
155. Ouellet M, Percival MD. Mechanism of acetaminophen inhibition of cyclooxygenase isoforms. Arch Biochem Biophys 2001;387:273-280.
156. Ovadia H, Wohlman A, Mechoulam R, Weidenfeld J. Characterization of the hypothermic effect of the synthetic cannabinoid HU-210 in the rat. Relation to the adrenergic system and endogenous pyrogens. Neuropharmacology 1994;34:175-180.
157. Page J, Henry D. Consumption of NSAIDs and the development of congestive heart failure in elderly patients: An underrecognized public health problem. Arch Intern Med 2000;160:777-784.
158. Pandolfini C, Bonati M. A literature review on off-label drug use in children. Eur J Pediatr 2005;164:552-558.
159. Patten CJ, Thomas PE, Guy RL, et al. Cytochrome P450 enzymes involved in acetaminophen activation by rat and human liver microsomes and their kinetics. Chem Res Toxicol 1993;6:511-518.
160. Perneger TV, Whelton, Klag MJ. Risk of kidney failure associated with use of acetaminophen, aspirin, and nonsteroidal antiinflammatory drugs. N Engl J Med 1994;331:1675-1679.
161. Pertwee RG. Cannabinoid receptors and pain. Prog Neurobiol 2001;63:569-611.
162. Perucca E, Richens A. Paracetamol disposition in normal subjects and in patients treated with antiepileptic drugs. Br J Clin Pharmacol 1979;7:201-206.
163. Peters JWB, Vulto AG, Grobee R, et al. Postoperative pain management in children following (adeno)tonsillectomy: Efficacy, pharmacokinetics and tolerability of paracetamol and diclofenac. Clin Drug Invest 1999;17(4):309-319.
164. Pini LA, Sandrini M, Vitale G. The antinociceptive action of paracetamol is associated with changes in the serotonergic system in the rat brain. Eur J Pharmacol 1996;308:31-40.
165. Piomelli D, Giuffrida A, Calignano A, Rodriguez de Fonseca F. The endocannabinoid system as a target for therapeutic drugs. Trends Pharmacol Sci 2000;21:218-224.
166. Pope JE, Anderson JJ, Felson DT. A meta-analysis of the effects of nonsteroidal anti-inflammatory drugs on blood pressure. Arch Intern Med 1993;153:477-484.
167. Prescott LF, Illingworth RN, Critchley JAH. Intravenous N-acetyl-cysteine: The treatment of choice for paracetamol poisoning. Br Med J 1979;2:1097-1100.
168. Prescott LF, Matthew H. Cysteamine for paracetamol overdosage. Lancet 1974;1:998.
169. Prescott LF, Proudfoot AT, Cregeen RJ. Paracetamol-induced acute renal failure in the absence of fulminant liver damage. Br Med J 1982;284:421-422.
170. Prescott LF, Roscoe P, Wright N, et al. Plasma-paracetamol half-life and hepatic necrosis in patients with paracetamol overdose. Lancet 1971;1:519-522.
171. Prescott LF, Steel RF, Ferner WR. The effects of particle size on the absorption of phenacetin in man. Clin Pharmacol Ther 1970;11:496-504.
172. Prescott LF. Analgesic nephropathy. Drugs 1982;23:75-149.
173. Prescott LF. Factor influencing paracetamol metabolism. In: Prescott LF, Ed. Paracetamol (acetaminophen). A Critical Bibliographic Review. London: Taylor & Francis, 1996;103-106.
174. Prescott LF. Gastrointestinal absorption of drugs. Med Clin N Am 1974;58:907-916.
175. st Edition. London: Taylor & Francis, 1996.
176. Prescott LF. Paracetamol overdosage. Pharmacological considerations and clinical management. Drugs 1983;25:290-314.
177. th Edition. Kidlington, Oxford: Elsevier Ltd, 2003.
178. Rawlins MD, Henderson DB, Hijab AR. Pharmacokinetics of paracetamol after intravenous and oral administration. Eur J Clin Pharmacol 1977;11(4):283-286.
179. Riano-Galan I, Gonzalez M, Sanchez SG, et al. Opinion de los pediatras sobre el dolor infantil. An Esp Pediatr 1998;49:587-593.
180. Richman DD, Fischl MA, Grieco MH, et al. The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. N Engl J Med 1987;317:192-197.
181. Rumack BH, Peterson RG. Acetaminophen overdose: Incidence, diagnosis and management in 416 patients. Pediatrics 1978;62(Suppl):898-903.
182. Rumack BH, Peterson RC, Koch GG, et al. Acetaminophen overdose. 662 cases with evaluation of oral acetylcysteine treatment. Arch Intern Med 1981;414:380-385.
183. Rumack BH, Peterson RG. Acetaminophen poisoning and toxicity. Pediatrics 1975;55:871-876.
184. Ruoff GE. The impact of nonsteroidal anti-inflammatory drugs on hypertension: Alternative analgesics for patients at risk. Clin Ther 1998;20:376-387.
185. Sahloul MZ, al-Kiek R, Ivanovich P, Mujais SK. Nonsteroidal anti-inflammatory drugs and antihypertensives: Cooperative malfeasance. Nephron 1990;56:345-352.
186. Sandrini M, Romualdi P, Vitale G, et al. The effect of a paracetamol and morphine combination on dynorphin A levels in the rat brain. Biochem Pharmacol 2001;61:1409-1416.
187. Sattler FR, Ko R, Antoniskis D, et al. Acetaminophen does not impair clearance of zidovudine. Ann Intern Med 1991;114:937-940.
188. Schachtel BP, Thoden WR. A placebo-controlled model for assaying systemic analgesics in children. J Clin Pharmacol Ther 1993;53:593-601.
189. Seeff LB, Cuccherini BA, Zimmerman HJ, et al. Acetaminophen hepatotoxicity in alcoholics. A therapeutic misadventure. Ann Intern Med 1986;104:309-404.
190. Seideman P, Alvan G, Andrews RS, Labross A. Relative bioavailability of a paracetamol suppository. Eur J Clin Pharmacol 1980;17(6):465-468.
191. Seigers CP, Loeser W, Gieselmann J, et al. Biliary and renal excretion of paracetamol in man. Pharmacology 1984;29:301-303.
192. Shaheen SO, Sterne JA, Songhurst CE, et al. Frequent paracetamol use and asthma in adults. Thorax 2000;55:266-270.
193. Skjelbred P, Album B, Lokken P. Acetylsalicylic acid vs paracetamol: Effects on postoperative course. Eur J Clin Pharmacol 1977;12:257-264.
194. Skjelbred P, Lokken P, Skoglund LA. Postoperative administration of acetaminophen to reduce swelling and other inflammatory events. Curr Ther Res 1984;35:377-385.
195. Skjelbred P, Lokken P. Paracetamol versus placebo: Effects on post-operative course. Eur J Clin Pharmacol 1979;15:27-33.
196. Skoglund LA, Skjelbred P, Fyllingen G. Analgesic efficacy of acetaminophen 1000 mg, acetaminophen 2000 mg, and the combination of acetaminophen 1000 mg and codeine phosphate 60 mg versus placebo in acute postoperative pain. Pharmacotherapy 1991;11:364-369.
197. Slattery JT, Koup JR, Levy G, et al. Acetaminophen pharmacokinetics after overdose. Clin Toxicol 1981;18:111-117.
198. Slattery JT, Wilson JM, Kalhorn TF, et al. Dose-dependent pharmacokinetics of acetaminophen: Evidence for glutathione depletion in humans. Clin Pharmacol Ther 1987;41:413-418.
199. Smilkstein MJ, Douglas DR, Daya MR. Acetaminophen poisoning and liver function. N Engl J Med 1994;330:1310-1311.
200. Smilkstein MJ, Knapp GL, Kulig KW, et al. Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose: Analysis of the national multicenter study (1976-1985). N Engl J Med 1988;3190:1557-1562.
201. Smith DW, Isakson G, Frankel LR, et al. Hepatic failure following ingestion of multiple doses of acetami-nophen in a young child. J Pediatr Gastroenterol Nutr 1986;5:822-825.
202. Smith PK. Acetophenetidin. A Critical Bibliographic Review. New York: Interscience Publishers, Inc., 1958.
203. th Edition. Auckland: Adis International Limited, 1997.
204. Spies CD, Reinhart K, Witt I, et al. Influence of N-acetylcysteine on indirect indicators of tissue oxygenation in septic shock patients. Crit Care Med 1994;22:1738-1746.
205. Steffe EM, King JH, Inciardi JF, et al. The effect of acetaminophen on zidovudine metabolism in HIV-infected patients. J AIDS 1990;3:691-694.
206. Steventon GB, Mitchell SC, Waring RH. Human metabolism of paracetamol (acetaminophen) at different dose levels. Drug Metab Drug Interact 1996;13(2):111-117.
207. Stillings M, Havlik I, Chetty M, et al. Comparison of the pharmacokinetic profiles of soluble aspirin and solid paracetamol tablets in fed and fasted volunteers. Curr Med Res Opin 2000;16(2):115-124.
208. Swetnam SM, Florman AL. Probable acetaminophen toxicity in an 18-month-old infant due to repeated overdosing. Clin Pediatr 1984;23:104-105.
209. Szallasi A, Blumberg PM. Vanilloid (Capsaicin) receptors and mechanisms. Pharmacol Rev 1999;51:159-212.
210. Szallasi A, DiMarzo V. New perspectives on enigmatic vanilloid receptors. Trends Neurosci 2000;23:491-497.
211. Thummel KE, Lee CA, Kunze KL, et al. Oxidation of acetaminophen to N-acetyl-p-aminobenzoquinone imine by human CYP3A4. Biochem Pharmacol 1993;45:1563-1569.
212. Thummel KE, Slattery JT, Nelson SD. Mechanism by which ethanol diminishes the hepatotoxicity of acetaminophen. J Pharmacol Exp Ther 1988;245:129-136.
213. Tjolsen A, Lund A, Hole K. Antinociceptive effect of paracetamol in rats is partly dependent on spinal serotonergic systems. Eur J Pharmacol 1991;193:193-201.
214. Tredger JM, Smith HM, Read RB, Williams R. Effects of ethanol ingestion on the metabolism of a hepatotoxic dose of paracetamol in mice. Xenobiotica 1986;16:661-670.
215. Triggs EJ, Nation RL, Long A, et al. Pharmacokinetics in the elderly. Eur J Clin Pharmacol 1975;8:55-62.
216. Urban L, Campbell EA, Panesar M, et al. In vivo pharmacology of SDZ 249-665, a novel, non-pungent capsaicin analogue. Pain 2000;89:65-74.
217. Van Lingen RA, Deinum JT, Quak JME, et al. Pharmacokinetics and metabolism of rectally administered paracetamol in preterm neonates. Arch Dis Child Fetal Neonatal Ed 1999;80:F59-F63.
218. Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol 1971;23:232-235.
219. Vinegar R, Truax FF, Selph JL. Quantitative comparison of the analgesic and anti-inflammatory activities of aspirin, phenacetin and acetaminophen in rodents. Eur J Pharmacol 1976;37:23-30.
220. Von Mering J. Beitrage zur Kenntniss der Antipyretica. Ther Monatsch 1893;7:577-587.
221. Walker JM, Huang SM. Cannabinoid analgesia. Pharmacol Ther 2002;95:127-135.
222. Ward B, Alexander-Williams JM. Paracetamol revisited: A review of the pharmacokinetics and pharmacodynamics. Acute Pain 1999;2:140-149.
223. Welborn CA. Pediatric migraine. Emerg Med Clin N Am 1997;15:625-636.
224. Wendon JA, Harrison PM, Keays R, et al. Cerebral blood flow and metabolism in fulminant liver failure. Hepatology 1994;19:1407-1413.
225. Whelton A, Fort JG, Puma JA, et al. Cyclooxygenase-2-specific inhibitors and cardiorenal function: A randomised, controlled trial of celecoxib and rofecoxib in older hypertensive osteoarthritis patients. Am J Ther 2001;8:85-95.
226. Whelton A, White WB, Bello AE, et al. Effects of celecoxib and rofecoxib on blood pressure and edema in patients >65 years of age with systemic hypertension and osteoarthritis. Am J Cardiol 2002;90:959-963.
227. Whelton A. Clinical implications of nonopioid analgesia for relief of mild-to-moderate pain in patients with or at risk for cardiovascular disease. Am J Cardiol 2006;97(Suppl 9A):3E-9E.
228. Whelton A. Renal aspects of treatment with conventional nonsteroidal anti-inflammatory drugs versus cyclooxygenase-2-specific inhibitors. Am J Med 2001;110(Suppl 3A):33S-42S.
229. Wilcox CM Jr. Gastrointestinal considerations in patients with cardiovascular disease using nonopioid analgesics for mild-to-moderate pain or cardioprotection. Am J Cardiol 2006;97(Suppl 9A):17E-22E.
230. Wilkinson SP, Moodie H, Arroyo VA, et al. Frequency of renal impairment in paracetamol overdose compared with other causes of acute liver damage. J Clin Pharmacol 1977;30:220-224.
231. Wong S, Gardocki JF. Anti-inflammatory and anti-arthritic evaluation of acetaminophen and its potentiation of tolmetin. J Pharmacol Exp Ther 1983;226:625-632.
232. rd edition. New York: The Macmillan Company, 1965:312-344
233. Young CR, Mazure CM. Fulminant hepatic failure from acetaminophen in an anorexic patient treated with carbamazepine [Letter]. J Clin Psychiatry 1998;59:622.
234. Zacharias M, Watts D. Pain relief in children. Doing the simple things better [Editorial]. Br Med J 1998;316:1552.
235. Zygmunt PM, Chuang H, Movahed P, et al. The anandamide transport inhibitor AM404 activates vanilloid receptors. Eur J Pharmacol 2000;396:39-42.